(Reuters) – Hologic Inc won emergency U.S. authorization to sell its Zika test, expanding the number of public and private labs that can test for the virus as health officials brace for a rise this summer in the number of infections. The U.S. Food and Drug Administration granted emergency use authorization for the company's Aptima test to detect Zika virus in human serum and plasma specimens. The test will be available for use immediately in every U.S. state as well as Puerto Rico and U.S. territories, the company said.
Original post:
Hologic wins emergency U.S. authorization for Zika test